Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

17.34
Delayed Data
As of 3:59pm ET
 -0.24 / -1.37%
Today’s Change
9.45
Today|||52-Week Range
18.70
+2.91%
Year-to-Date
4 Biotech Stock Charts You Must See
Aug 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close17.58
Today’s open17.58
Day’s range16.99 - 18.01
Volume1,038,294
Average volume (3 months)967,490
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-75.68%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book369.95

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-1.32-2.42%
EXASExact Sciences Corp+0.08+0.42%
KITEKite Pharma Inc+0.38+0.66%
ARIAARIAD Pharmaceutical...+0.18+1.80%
Data as of 3:59pm ET, 08/25/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs